Drreddys Laboratories | Betriebsaufwand



Operating Expenses Veränderung Datum
ANI Pharmaceuticals USD 170.93M 24.02M 2025-03
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bayer EUR 11.41B 3.22B 2025-03
Canopy Growth CAD 98.58M 10.03M 2024-12
Cipla INR 55.01B 1.37B 2025-03
Corcept Therapeutics USD 153.8M 2.83M 2025-03
Drreddys Laboratories INR 64.87B 2.26B 2024-12
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Lonza CHF 2.52B 776M 2024-06
Novartis USD 11.28B 1.73B 2024-12
Pacira USD 166.93M 4.38M 2025-03
Prestige Brands USD 208.09M 9.74M 2025-03
Richter Gedeon HUF 153.02B 2.72B 2024-09
Sun Pharmaceuticals INR 104.3B 3.51B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Teva Pharmaceutical Industries USD 3.37B 402M 2025-03



Drreddys Laboratories Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.